Maintenance status of N95 respirator masks after use in a health care setting;Estado de conservação de respiradores PFF-2 após uso na rotina hospitalar

Revista da Escola de Enfermagem

Volumn 44, Issue 4, 2010, Pages 1011-1016

  Duarte, Laura Regina Parreira ^a   Miola, Claudio Eduardo ^a   Cavalcante, Nilton José Fernandes ^b   Bammann, Ricardo Helbert ^b  

^a INSTITUTO DE INFECTOLOGIA EMÍLIO RIBAS   (Brazil)

^b Secretaria de Estado da Saude de Sao Paulo   (Brazil)

Author keywords

Occupational health; Protective devices; Respiratory protective devices; Tuberculosis

Indexed keywords

ARTICLE; FEMALE; GAS MASK; HUMAN; MALE; PROSPECTIVE STUDY; STANDARD; TIME;

FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; RESPIRATORY PROTECTIVE DEVICES; TIME FACTORS;

EID: 78650469983     PISSN: 00806234     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0080-62342010000400022     Document Type: Article

References (17)

1. Jensen PA, Lambert LA, Iademarco MF, Ridzon R, Centers for Disease Control and Prevention (CDC). Guidelines for preventing the transmission of Mycobacterium tuberculosis in health care settings, 2005. MMWR Recomm Rep. 2005;54(RR-17):1-141.
2. Centers for Disease Control and Prevention (CDC). Laboratory performance evaluation of N95 facepiece respirators, 1996. MMWR Morb Mortal Wkly Rep. 1998;47(48):1045-9.
3. Fennelly KP. Personal respiratory protection against Mycobacterium tuberculosis. Clin Chest Med. 1997;18(1):1-17.
4. Brasil. Ministério do Trabalho e Emprego. Norma Regulamentadora NR 6 - Equipamentos de Proteção Individual - EPI [legislação na Internet]. Brasília; 2006. [citado 2007 fev. 12]. Disponível em: http://www.mte.gov.br/legislacao/normas_regulamentadoras/nr_06.pdf
5. 3M Company. Reusable respirator facepieces and powered air purifying respirator systems (PAPRs) in the health care environment: considerations for use. Technical Data Bulletim #160. St. Paul, Minnesota; 2003. p. 1-6.
6. Rengasamy A, Zhuang Z, BerryAnn R. Respiratory protection against bioaerosols: literature review and research needs. Am J Infect Control. 2004;32(6):345-54.
7. Nishide VM, Benatti MCC. Riscos ocupacionais entre trabalhadores de enfermagem de uma unidade de terapia intensiva. Rev Esc Enferm USP. 2004;38(4):406-14.
8. Foo CC, Goon AT, Leow YH, Goh CL. Adverse skin reactions to personal protective equipment against severe acute respiratory syndrome: a descriptive study in Singapore. Contact Dermatitis. 2006;55(5):291-4.
9. Lim EC, Seet RC, Lee KH, Wilder-Smith EP, Chuah BY, Ong BK. Headaches and the N95 face-mask among healthcare providers. Acta Neurol Scand. 2006;113(3):199-202.
10. Biscotto CR, Pedroso ER, Starling CE, Roth VR. Evaluation of N95 respirator use as a tuberculosis control measure in a resourcelimited setting. Int J Tuberc Lung Dis. 2005;9(5):545-9.
11. Luksamijarulkul P, Supapvanit C, Loosereewanich P, Aiumlaor P. Risk assessment towards tuberculosis among hospital personnel: administrative control, risk exposure, use of protective barriers and microbial air quality. Southeast Asian J Trop Med Public Health. 2004;35(4):1005-11.
12. Fennely KP. The role of masks in preventing nosocomial transmission of tuberculosis. Int J Tuberc Lung Dis. 1998;2 (9):S103-9.
13. Pasanen AL, Keinanan J, Kalliokoski P, Martikainen P, Ruuskanen J. Microbial growth on respirator filters from improper storage. Scand J Work Environ Health. 1993;19(6):421-5.
14. Reponen TA, Wang Z, Willeke K, Grinshpun SA. Survival of mycobacteria on N95 personal respirators. Infect Control Hosp Epidemiol. 1999;20(4):237-41.
15. Lee K, Slavcev A, Nicas M. Respiratory protection against Mycobacterium tuberculosis: quantitative fit test outcomes for five type N95 filtering-facepiece respirators. J Occup Environ Hyg. 2004;1(1):22-8.
16. Hong SW. Preventing nosocomial Mycobacterium tuberculosis transmission in international settings. Emerg Infect Dis. 2001;7(2):245-8.
17. World Health Organization (WHO). Addendum to the Guidelines for the Prevention in Health Care Facilities in Resource-Limited Settings. Geneva; 2006. (WHO/TB/99.269).